99 related articles for article (PubMed ID: 2620541)
41. The spectrum of coronary artery pathologic findings in human cardiac allografts.
Johnson DE; Gao SZ; Schroeder JS; DeCampli WM; Billingham ME
J Heart Transplant; 1989; 8(5):349-59. PubMed ID: 2795279
[TBL] [Abstract][Full Text] [Related]
42. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M
J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
[TBL] [Abstract][Full Text] [Related]
43. Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development.
Adams DH; Wyner LR; Karnovsky MJ
Transplantation; 1993 Oct; 56(4):794-9. PubMed ID: 8212197
[TBL] [Abstract][Full Text] [Related]
44. Contribution of proliferating leukocytes to phenotypic change in smooth muscle cells during the development of coronary arteriosclerosis in transplanted hearts.
Shirasawa B; Hamano K; Ueda M; Ito H; Kobayashi T; Fujimura Y; Kojima A; Esato K
Eur Surg Res; 2000; 32(1):30-8. PubMed ID: 10720843
[TBL] [Abstract][Full Text] [Related]
45. Changes in the morphology and components of the coronary arteries during the progression of coronary arteriosclerosis following cardiac transplantation in rats.
Hamano K; Ito H; Fujimura Y; Tsuboi H; Esato K
Cardiovasc Surg; 1998 Jun; 6(3):296-301. PubMed ID: 9705103
[TBL] [Abstract][Full Text] [Related]
46. Correlation between proliferating cell nuclear antigen expression and phenotypic change in smooth muscle cells during the development of vasculopathy in heterotopically transplanted rat hearts.
Shirasawa B; Hamano K; Ueda M; Kojima A; Kobayashi T; Ito H; Gohra H; Katoh T; Zempo N; Esato K
Transplant Proc; 2000 Nov; 32(7):1995-6. PubMed ID: 11120035
[No Abstract] [Full Text] [Related]
47. Smooth muscle cells and macrophages in rabbit cardiac allograft atherosclerosis.
Beranek JT; Cavarocchi NC
J Heart Transplant; 1990; 9(6):732. PubMed ID: 2277312
[No Abstract] [Full Text] [Related]
48. Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts. A study in rat and monkey models.
Suzuki J; Isobe M; Aikawa M; Kawauchi M; Shiojima I; Kobayashi N; Tojo A; Suzuki T; Kimura K; Nishikawa T; Sakai T; Sekiguchi M; Yazaki Y; Nagai R
Circulation; 1996 Sep; 94(5):1118-24. PubMed ID: 8790054
[TBL] [Abstract][Full Text] [Related]
49. Accelerated graft arteriosclerosis is enhanced by sensitization of the recipient to donor lymphocytes.
Cramer DV; Qian S; Harnaha J; Chapman FA; Starzl TE; Makowka L
Transplant Proc; 1989 Aug; 21(4):3714-5. PubMed ID: 2669282
[No Abstract] [Full Text] [Related]
50. Gene transfer and expression in rat cardiac transplants.
Wang J; Jiao S; Wolff JA; Knechtle SJ
Transplantation; 1992 Mar; 53(3):703-5. PubMed ID: 1549875
[No Abstract] [Full Text] [Related]
51. Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit.
Kuwahara M; Jacobsson J; Kuwahara M; Kagan E; Ramwell PW; Foegh ML
Transplantation; 1991 Nov; 52(5):759-65. PubMed ID: 1949159
[TBL] [Abstract][Full Text] [Related]
52. Effect of angiopeptin and aspirin on accelerated graft atherosclerosis in transplanted mouse heart.
Lee JR; Yang JH; Kim EK; Seo JW
J Korean Med Sci; 1999 Dec; 14(6):607-12. PubMed ID: 10642937
[TBL] [Abstract][Full Text] [Related]
53. Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
Teranishi K; Poston RS; Reitz BA; Robbins RC
Transplant Proc; 1998 Jun; 30(4):1009-11. PubMed ID: 9636408
[No Abstract] [Full Text] [Related]
54. Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation.
Eich DM; Nestler JE; Johnson DE; Dworkin GH; Ko D; Wechsler AS; Hess ML
Circulation; 1993 Jan; 87(1):261-9. PubMed ID: 8419015
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease.
Ravalli S; Marboe CC; D'Agati VD; Michler RE; Sigal E; Cannon PJ
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):340-8. PubMed ID: 7749844
[TBL] [Abstract][Full Text] [Related]
56. The effect of donor age in graft coronary atherosclerosis after cardiac transplantation.
Kobayashi Y; Fukushima N; Ohtake S; Sawa Y; Nishimura M; Matsumiya G; Horiguchi K; Matsuda H
Transplant Proc; 2002 Nov; 34(7):2587-8. PubMed ID: 12431534
[No Abstract] [Full Text] [Related]
57. Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus.
De La Melena VT; Kreklywich CN; Streblow DN; Yin Q; Cook JW; Soderberg-Naucler C; Bruggeman CA; Nelson JA; Orloff SL
Transplant Proc; 2001; 33(1-2):1822-3. PubMed ID: 11267529
[No Abstract] [Full Text] [Related]
58. Peptide inhibition of accelerated transplant atherosclerosis.
Foegh ML; Khirabadi BS; Chambers E; Ramwell PW
Transplant Proc; 1989 Aug; 21(4):3674-6. PubMed ID: 2569776
[No Abstract] [Full Text] [Related]
59. Inducible expression of BTEB2, a member of the zinc-finger family of transcription factors, in cardiac allograft arteriosclerosis.
Ogata T; Kurabayashi M; Hoshino Y; Ishikawa S; Takeyoshi I; Morishita Y; Nagai R
Transplant Proc; 2000 Nov; 32(7):2032-3. PubMed ID: 11120052
[No Abstract] [Full Text] [Related]
60. Inducible expression of basic transcription factor-binding protein 2 (BTEB2), a member of zinc finger family of transcription factors, in cardiac allograft vascular disease.
Ogata T; Kurabayashi M; Hoshino YI; Sekiguchi KI; Kawai-Kowase K; Ishikawa S; Morishita Y; Nagai R
Transplantation; 2000 Dec; 70(11):1653-6. PubMed ID: 11152229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
